Wolf Group Capital Advisors Astrazeneca PLC Transaction History
Wolf Group Capital Advisors
- $290 Million
- Q1 2025
A detailed history of Wolf Group Capital Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Wolf Group Capital Advisors holds 3,555 shares of AZN stock, worth $250,769. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,555Holding current value
$250,769% of portfolio
0.09%Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.03 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.87 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.25 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.21 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $219B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...